108 related articles for article (PubMed ID: 7982239)
41. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
[TBL] [Abstract][Full Text] [Related]
42. Determining the cut-off value of pro-gastrin releasing peptide (ProGRP) in lung cancer according to population characteristics.
Bubanović G; Pavićević R; Franjević A
Coll Antropol; 2008 Dec; 32(4):1155-64. PubMed ID: 19149223
[TBL] [Abstract][Full Text] [Related]
43. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.
Joseph MG; Banerjee D; Kocha W; Feld R; Stitt LW; Cherian MG
Cancer; 2001 Aug; 92(4):836-42. PubMed ID: 11550155
[TBL] [Abstract][Full Text] [Related]
44. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
[TBL] [Abstract][Full Text] [Related]
45. Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.
Dickler MN; Ragupathi G; Liu NX; Musselli C; Martino DJ; Miller VA; Kris MG; Brezicka FT; Livingston PO; Grant SC
Clin Cancer Res; 1999 Oct; 5(10):2773-9. PubMed ID: 10537341
[TBL] [Abstract][Full Text] [Related]
46. Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin.
Krug LM; Ragupathi G; Hood C; Kris MG; Miller VA; Allen JR; Keding SJ; Danishefsky SJ; Gomez J; Tyson L; Pizzo B; Baez V; Livingston PO
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6094-100. PubMed ID: 15447995
[TBL] [Abstract][Full Text] [Related]
47. Serum immunoassay of a small cell lung cancer associated ganglioside: development of a sensitive scintillation proximity assay.
Pallesen T; Vangsted A; Drivsholm L; Clausen H; Zeuthen J; Wallin H
Glycoconj J; 1992 Dec; 9(6):331-5. PubMed ID: 1339041
[TBL] [Abstract][Full Text] [Related]
48. An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker.
Gordon SG; Cross BA
Cancer Res; 1990 Oct; 50(19):6229-34. PubMed ID: 2169340
[TBL] [Abstract][Full Text] [Related]
49. [The use of monoclonal antibodies in the detection of small cell lung cancer metastases in bone marrow].
Obłakowski P; Pacuszka T; Rogińska E; Remiszewski P; Załeska J; Zych J; Roszkowski K; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 1999; 67(1-2):53-9. PubMed ID: 10481525
[TBL] [Abstract][Full Text] [Related]
50. Small cell lung cancer is not associated with the presence of anti-fucosyl-GM1 ganglioside autoantibodies reactive in immunoenzymatic test.
Adler G; Pacuszka T; Lewartowska A; Rowinska E; Oblakowski P; Panasiewicz M
Lung Cancer; 2001 Dec; 34(3):383-5. PubMed ID: 11714535
[TBL] [Abstract][Full Text] [Related]
51. Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer--the ganglioside antigen fucosyl-GM1.
Vangsted AJ; Zeuthen J
Acta Oncol; 1993; 32(7-8):845-51. PubMed ID: 8305235
[TBL] [Abstract][Full Text] [Related]
52. Identification of candidate serum biomarkers for small cell lung cancer by proteomics analysis.
Shi J; Liu J; Liao L; Guo Y; Wang H; Hu W; Hu T
Minerva Med; 2014 Apr; 105(2):137-47. PubMed ID: 24727878
[TBL] [Abstract][Full Text] [Related]
53. Neural cell adhesion molecule expression and clinical features in small cell lung cancer: a semi-quantitative immunohistochemical approach using an immunogold-silver staining method.
Segawa Y; Ohnoshi T; Ueoka H; Kimura I
Acta Med Okayama; 1993 Aug; 47(4):281-7. PubMed ID: 8213222
[TBL] [Abstract][Full Text] [Related]
54. Influence of tumor burden on red blood cell deformability in small cell lung cancer patients.
Cohen MH
Ann Clin Res; 1981 Dec; 13(6):387-91. PubMed ID: 6291443
[TBL] [Abstract][Full Text] [Related]
55. [Incidence of beta HCG elevation in serum of patients with small cell lung neoplasms and their prognosis].
Szturmowicz M; Wiatr E; Sakowicz A; Szczepek B; Filipecki S; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 1995; 63(11-12):621-6. PubMed ID: 8616477
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic relevance of circulating biomarkers in patients with lung cancer.
Molina R; Holdenrieder S; Auge JM; Schalhorn A; Hatz R; Stieber P
Cancer Biomark; 2010; 6(3-4):163-78. PubMed ID: 20660962
[TBL] [Abstract][Full Text] [Related]
57. [The use of monoclonal antibodies that recognize the neural cell adhesion molecule (NCAM) in the diagnosis of bone marrow localization of small cell lung cancer].
Pasini F; Pelosi G; Santo A; Zaninelli M; Mostacci R; Masotti A; Spagnolli P; Recaldin E; Cetto GL
Minerva Med; 1994 Sep; 85(9):433-8. PubMed ID: 7936364
[TBL] [Abstract][Full Text] [Related]
58. Expression of neural cell adhesion molecules (polysialylated form of neural cell adhesion molecule and L1-cell adhesion molecule) on resected small cell lung cancer specimens: in relation to proliferation state.
Miyahara R; Tanaka F; Nakagawa T; Matsuoka K; Isii K; Wada H
J Surg Oncol; 2001 May; 77(1):49-54. PubMed ID: 11344483
[TBL] [Abstract][Full Text] [Related]
59. Splicing of the VASE exon of neural cell adhesion molecule (NCAM) in human small-cell lung carcinoma (SCLC).
van Duijnhoven HL; Helfrich W; de Leij L; Roebroek AJ; van de Ven WJ; Healey K; Culverwell A; Rossell RJ; Kemshead JT; Patel K
Int J Cancer; 1992 Jan; 50(1):118-23. PubMed ID: 1339414
[TBL] [Abstract][Full Text] [Related]
60. Neural cell adhesion molecule expression in thyroid cancer.
Miyajima Y; Ota S; Yasukawa H; Zenmyou M; Morimatsu M; Kashiwagi S; Hirano M
Oncol Rep; 1996 Jan; 3(1):63-7. PubMed ID: 21594316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
